Cancer BiologybioRxivPreprint
Predicting Neoantigen Immunogenicity from In Vivo Immune Editing
Timothy J. Sears, Ko-Han Lee, María Muñoz Pérez…·Hannah K. Carter
This paper introduces NEMo, a machine learning model that predicts neoantigen immunogenicity using in vivo immune editing data, showing improved stratification of progression-free survival across multiple clinical settings.
DOI 10.64898/2026.09.17.752425